Related references
Note: Only part of the references are listed.Predictors of Cancer Risk in the Long-Term Solid-Organ Transplant Recipient
Sam N. Sherston et al.
TRANSPLANTATION (2014)
Regulatory dendritic cells for immunotherapy in immunologic diseases
John R. Gordon et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs
Lesley A. Smyth et al.
JOURNAL OF IMMUNOLOGY (2013)
Complications of Transplant for Nonmalignant Disorders: Autoimmune Cytopenias, Opportunistic Infections, and PTLD
Christopher C. Dvorak et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity
Elizabeth O. Stenger et al.
BLOOD (2012)
Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation
Martijn W. F. van den Hoogen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
The evolution of the danger theory
Polly Matzinger
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
Crosstalk between Human IgG Isotypes and Murine Effector Cells
Marije B. Overdijk et al.
JOURNAL OF IMMUNOLOGY (2012)
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease
Motoko Koyama et al.
NATURE MEDICINE (2012)
Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation
Xiaojian Wang et al.
BLOOD (2011)
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin
C. Garcia-Rodriguez et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression
Weston P. Miller et al.
BLOOD (2010)
A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies
Martina L. Jones et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Internalizing Cancer Antibodies from Phage Libraries Selected on Tumor Cells and Yeast-Displayed Tumor Antigens
Yu Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
Kerstin Steinbrink et al.
HUMAN IMMUNOLOGY (2009)
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
John Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
David Gomez-Almaguer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
CD83 expression in CD4+ T cells modulates inflammation and autoimmunity
Simone Reinwald et al.
JOURNAL OF IMMUNOLOGY (2008)
The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo
Matthias Lechmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem-Cell Transplant Determines the Kinetics of Acute Graft-Versus-Host Disease
Brie E. Turner et al.
TRANSPLANTATION (2008)
CD83 regulates lymphocyte maturation, activation and homeostasis
Minka Breloer et al.
TRENDS IN IMMUNOLOGY (2008)
Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease
Jenny Lau et al.
TRANSPLANTATION (2007)
Ultra-potent antibodies against respiratory syncytial virus: Effects of binding kinetics and binding valence on viral neutralization
H Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Donor APCs are required for maximal GVHD but not for GVL
CC Matte et al.
NATURE MEDICINE (2004)
Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity
DJ Munster et al.
INTERNATIONAL IMMUNOLOGY (2004)
Characterization of human blood dendritic cell subsets
KPA MacDonald et al.
BLOOD (2002)
A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera
BD Hock et al.
INTERNATIONAL IMMUNOLOGY (2001)
Share Paper
